Expression of cannabinoid 1 and, 2 receptors and the effects of cannabinoid 1 and, 2 receptor agonists on detrusor overactivity associated with bladder outlet obstruction in rats

Springer Science and Business Media LLC - Tập 17 - Trang 1-7 - 2017
Sung Dae Kim1, Kang Jun Cho2, Joon Chul Kim2
1Department of Urology, Graduate School of Medicine, Jeju National University, Jeju, South Korea
2Department of Urology, Bucheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea

Tóm tắt

This study investigated changes in the expression of cannabinoid (CB) receptors and the effects of CB1 and CB2 agonists on detrusor overactivity (DO) associated with bladder outlet obstruction (BOO) in rats. Male Sprague Dawley rats were randomly assigned to four groups (n = 10) in each group. The control group comprised sham-operated rats. A animals in the BOO, CB1 agonist and CB2 agonist groups all underwent BOO surgery. Three weeks postoperatively, cystometrography (CMG) was performed on all rats. After confirming the presence of DO in the CB1 and CB2 agonist groups, a CB1 agonist (WIN 55,212–2) and a CB2 agonist (CB65) were instilled intravesically, and CMG was repeated. CMG parameters, including the contraction interval (CI) and contraction pressure (CP) were then analyzed. The bladders of rats in all four groups were excised following CMG. Immunofluorescence staining and Western blotting were performed to localize CB1 and CB2 and measure their expression levels in the urothelium and detrusor muscle. The CI was significantly longer and the CP was significantly lower in the CB1 agonist group than in the BOO group. CI and CP in the CB2 agonist group showed the same results. CB1 receptor immunofluorescence staining signals and immunoreactive bands in Western blotting were increased in the BOO group compared with results in the control group. Similarly, results for the CB2 receptor were also increased in the BOO group, although this difference was not significant. The CMG parameters in the BOO group were significantly improved by the inhibitory effects of CB1 and CB2 agonists on BOO-associated DO. The expression of CB1 was significantly increased in the urothelium and detrusor muscle in BOO-associated DO, but no significant change in CB2 expression was observed. CB1 and CB2 receptors, especially CB1, play a role in the pathophysiology of BOO-associated DO, and could serve as therapeutic targets.

Tài liệu tham khảo

de Nunzio C, Franco G, Rocchegiani A, Iori F, Leonardo C, Laurenti C. The evolution of detrusor overactivity after watchful waiting, medical therapy and surgery in patients with bladder outlet obstruction. J Urol. 2003;169:535–9.

Andersson KE. Bladder activation: afferent mechanisms. Urology. 2002;59(5 Suppl 1):43–50.

Fowler CJ. Bladder afferents and their role in the overactive bladder. Urology. 2002;59(5 Suppl 1):37–42.

Kim HS, Park WJ, Park EY, Koh JS, Hwang TK, Kim JC. Role of nicotinic acetylcholine receptor α3 and α7 subunits in detrusor Overactivity induced by partial bladder outlet obstruction in rats. Int Neurourol J. 2015;19:12–8.

Cho KJ, Park EY, Kim HS, Koh JS, Kim JC. Expression of transient receptor potential vanilloid 4 and effects of ruthenium red on detrusor overactivity associated with bladder outlet obstruction in rats. World J Urol. 2014;32:677–82.

Kim DY, Yang EK. 17 Beta-estradiol inhibits calcium-activated Potassium Channel expressions in rat whole bladder. Int Neurourol J. 2016;20:18–25.

Ben Amar M. Cannabinoids in medicine: a review of their therapeutic potential. J Ethnopharmacol. 2006;105:1–25.

Tyagi V, Philips BJ, Su R, Smaldone MC, Erickson VL, Chancellor MB, et al. Differential expression of functional cannabinoid receptors in human bladder detrusor and urothelium. J Urol. 2009;181:1932–8.

Boudes M, De Ridder D. Cannabinoid receptor 1 also plays a role in healthy bladder. BJU Int. 2014;113:142–3.

Brady CM, DasGupta R, Dalton C, Wiseman OJ, Berkley KJ, Fowler CJ. An open-label pilot study of cannabis-based extracts for bladder dysfunction in advanced multiple sclerosis. Mult Scler. 2004;10:425–33.

Goonawardena AV, Plano A, Robinson L, Platt B, Hampson RE, Riedel G. A Pilot Study into the Effects of the CB1 Cannabinoid Receptor Agonist WIN55,212-2 or the Antagonist/Inverse Agonist AM251 on Sleep in Rats. Sleep Disord. 2011. https://doi.org/10.1155/2011/178469.

Gratzke C, Streng T, Stief CG, Alroy I, Limberg BJ, Downs TR, et al. Cannabinor, a selective cannabinoid-2 receptor agonist, improves bladder emptying in rats with partial urethral obstruction. J Urol. 2011;185:731–6.

Walczak JS, Price TJ, Cervero F. Cannabinoid CB1 receptors are expressed in the mouse urinary bladder and their activation modulates afferent bladder activity. Neuroscience. 2009;159:1154–63.

Parsons BA, Drake MJ. Animal models in overactive bladder research. Handb Exp Pharmacol. 2011;202:15–43.

Fry CH, Daneshgari F, Thor K, Drake M, Eccles R, Kanai AJ, et al. Animal models and their use in understanding lower urinary tract dysfunction. Neurourol Urodyn. 2010;29:603–8.

Hedlund P. Cannabinoids and the endocannabinoid system in lower urinary tract function and dysfunction. Neurourol Urodyn. 2014;33:46–53.

Wang ZY, Wang P, Bjorling DE. Activation of cannabinoid receptor 1 inhibits increased bladder activity induced by nerve growth factor. Neurosci Lett. 2015;589:19–24.

Freeman RM, Adekanmi O, Waterfield MR, Waterfield AE, Wright D, Zajicek J. The effect of cannabis on urge incontinence in patients with multiple sclerosis: a multicentre, randomised placebo-controlled trial (CAMS-LUTS). Int Urogynecol J Pelvic Floor Dysfunct. 2006;17:636–41.

Füllhase C, Campeau L, Sibaev A, Storr M, Hennenberg M, Gratzke C, et al. Bladder function in a cannabinoid receptor type 1 knockout mouse. BJU Int. 2014;113:144–51.

Füllhase C, Russo A, Castiglione F, Benigni F, Campeau L, Montorsi F, et al. Spinal cord FAAH in normal micturition control and bladder overactivity in awake rats. J Urol. 2013;189:2364–70.

Gratzke C, Streng T, Park A, Christ G, Stief CG, Hedlund P, et al. Distribution and function of cannabinoid receptors 1 and 2 in the rat, monkey and human bladder. J Urol. 2009;181:1939–48.

Merriam FV, Wang ZY, Guerios SD, Bjorling DE. Cannabinoid receptor 2 is increased in acutely and chronically inflamed bladder of rats. Neurosci Lett. 2008;445:130–4.

Bakali E, Elliott RA, Taylor AH, Willets J, Konje JC, Tincello DG. Distribution and function of the endocannabinoid system in the rat and human bladder. Int Urogynecol J. 2013;24:855–63.

Bakali E, McDonald J, Elliott RA, Lambert DG, Tincello DG. Cannabinoid receptor expression in the bladder is altered in detrusor overactivity. Int Urogynecol J. 2016;27:129–39.

Ozkurkcugil C, Ozkan L. Effects of anesthetics on cystometric parameters in female rats. Int Urol Nephrol. 2010;42:909–13.

Thông tin
Thông tin xuất bản

Springer Science and Business Media LLC

Tập 17

1-7

Thông tin tác giả